ITMI912071A1 - Forme farmaceutiche antivirali per applicazione vaginale - Google Patents

Forme farmaceutiche antivirali per applicazione vaginale

Info

Publication number
ITMI912071A1
ITMI912071A1 IT002071A ITMI912071A ITMI912071A1 IT MI912071 A1 ITMI912071 A1 IT MI912071A1 IT 002071 A IT002071 A IT 002071A IT MI912071 A ITMI912071 A IT MI912071A IT MI912071 A1 ITMI912071 A1 IT MI912071A1
Authority
IT
Italy
Prior art keywords
pharmaceutical forms
vaginal application
antiviral pharmaceutical
tablets
bioadhesive
Prior art date
Application number
IT002071A
Other languages
English (en)
Inventor
Ubaldo Conte
Lauretta Maggi
Original Assignee
Farcon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farcon Ag filed Critical Farcon Ag
Publication of ITMI912071A0 publication Critical patent/ITMI912071A0/it
Priority to ITMI912071A priority Critical patent/IT1251114B/it
Priority to DE69205579T priority patent/DE69205579T2/de
Priority to JP5503217A priority patent/JPH06509348A/ja
Priority to EP92915980A priority patent/EP0596935B1/en
Priority to AT92915980T priority patent/ATE129149T1/de
Priority to PCT/EP1992/001655 priority patent/WO1993002662A1/en
Priority to AU23454/92A priority patent/AU2345492A/en
Priority to DK92915980.4T priority patent/DK0596935T3/da
Priority to CA002114216A priority patent/CA2114216A1/en
Priority to CN92111077A priority patent/CN1082894A/zh
Publication of ITMI912071A1 publication Critical patent/ITMI912071A1/it
Application granted granted Critical
Publication of IT1251114B publication Critical patent/IT1251114B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI912071A 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale IT1251114B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI912071A IT1251114B (it) 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale
AT92915980T ATE129149T1 (de) 1991-07-26 1992-07-20 Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.
JP5503217A JPH06509348A (ja) 1991-07-26 1992-07-20 経膣投与用の抗ウイルス性薬剤組成物
EP92915980A EP0596935B1 (en) 1991-07-26 1992-07-20 Antiviral pharmaceutical compositions for vaginal administration
DE69205579T DE69205579T2 (de) 1991-07-26 1992-07-20 Virushemmende pharmazeutische zubereitungen zur vaginalen verabreichung.
PCT/EP1992/001655 WO1993002662A1 (en) 1991-07-26 1992-07-20 Antiviral pharmaceutical compositions for vaginal administration
AU23454/92A AU2345492A (en) 1991-07-26 1992-07-20 Antiviral pharmaceutical compositions for vaginal administration
DK92915980.4T DK0596935T3 (da) 1991-07-26 1992-07-20 Antivirale farmaceutiske midler til vaginal administration
CA002114216A CA2114216A1 (en) 1991-07-26 1992-07-20 Antiviral pharmaceutical compositions for vaginal administration
CN92111077A CN1082894A (zh) 1991-07-26 1992-08-24 阴道给药的抗病毒药物组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI912071A IT1251114B (it) 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale
CN92111077A CN1082894A (zh) 1991-07-26 1992-08-24 阴道给药的抗病毒药物组合物

Publications (3)

Publication Number Publication Date
ITMI912071A0 ITMI912071A0 (it) 1991-07-26
ITMI912071A1 true ITMI912071A1 (it) 1993-01-27
IT1251114B IT1251114B (it) 1995-05-04

Family

ID=36790864

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912071A IT1251114B (it) 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale

Country Status (10)

Country Link
EP (1) EP0596935B1 (it)
JP (1) JPH06509348A (it)
CN (1) CN1082894A (it)
AT (1) ATE129149T1 (it)
AU (1) AU2345492A (it)
CA (1) CA2114216A1 (it)
DE (1) DE69205579T2 (it)
DK (1) DK0596935T3 (it)
IT (1) IT1251114B (it)
WO (1) WO1993002662A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
DE4404011A1 (de) * 1994-02-09 1995-08-10 Jenapharm Gmbh Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
RU2310474C2 (ru) 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
JP2001240558A (ja) * 2000-02-29 2001-09-04 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
CA2422424C (en) * 2000-09-19 2009-12-01 Cima Labs, Inc. Pharmaceutical compositions for rectal and vaginal administration
CA2540129A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
NZ548216A (en) 2003-12-31 2010-02-26 Cima Labs Inc Generally linear effervescent oral fentanyl dosage form and methods of administering
US7862833B2 (en) 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
EP2662086A1 (en) * 2012-05-08 2013-11-13 Progressare Medinvest B.V. Composition for the treatment or prevention of urinary tract infections and dosage form

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
IT1187750B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release

Also Published As

Publication number Publication date
EP0596935B1 (en) 1995-10-18
JPH06509348A (ja) 1994-10-20
CA2114216A1 (en) 1993-02-18
DE69205579T2 (de) 1996-04-04
IT1251114B (it) 1995-05-04
DE69205579D1 (de) 1995-11-23
ITMI912071A0 (it) 1991-07-26
ATE129149T1 (de) 1995-11-15
AU2345492A (en) 1993-03-02
CN1082894A (zh) 1994-03-02
WO1993002662A1 (en) 1993-02-18
DK0596935T3 (da) 1996-01-22
EP0596935A1 (en) 1994-05-18

Similar Documents

Publication Publication Date Title
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
KR960702303A (ko) 항억제제 제형 (Antidepressant Dosage Form)
ITMI912071A1 (it) Forme farmaceutiche antivirali per applicazione vaginale
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
IT8767057A0 (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
IT9019112A0 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ATE173930T1 (de) Pharmazeutische zusammensetzungen zur topischen anwendung die ein chelatierungsmittel, ein tocopherol und einen antimikrobiellen wirkstoff enthalten
IT1291340B1 (it) Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
SE0001916D0 (sv) Novel formulation
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
FR2709959B1 (fr) Nouvelle forme galénique de phloroglucinol.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
IT1251160B (it) Impiego di composti adenosinici nel trattamento dell'ischemia
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
OA09301A (fr) "Nouvelle forme galénique orale améliorant la biodisponibilité".
FR2618676B1 (fr) Compositions pharmaceutiques antivirales
DE69000384D1 (de) Wasserloeschlicher glasiger wirkstoff fuer die wasserbehandlung.
IT1237197B (it) Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725